Regarding 'HPV vaccination for cervical cancer prevention is not cost-effective in Japan'.

Tytuł:: Regarding 'HPV vaccination for cervical cancer prevention is not cost-effective in Japan'.
Autorzy:: Arakawa I; Unit of Health Economics, Faculty of Pharmaceutical Science, Teikyo Heisei University, Japan E-mail : .
Murasawa H
Konno R
Źródło:: Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2015; Vol. 16 (6), pp. 2583-4.
Typ publikacji:: Letter; Comment
Język:: English
Imprint Name(s):: Original Publication: Bangkok : Asian Pacific Organization for Cancer Prevention,
MeSH Terms:: Papillomavirus Infections/*prevention & control
Uterine Cervical Neoplasms/*prevention & control
Cost-Benefit Analysis ; Humans ; Japan ; Papillomavirus Vaccines ; Vaccination
Substance Nomenclature:: 0 (Papillomavirus Vaccines)
Entry Date(s):: Date Created: 20150401 Date Completed: 20160824 Latest Revision: 20190606
Update Code:: 20240104
DOI:: 10.7314/apjcp.2015.16.6.2583
PMID:: 25824801
: Opinia redakcyjna

Full Text Finder

Comment on: Asian Pac J Cancer Prev. 2014;15(15):6177-80. (PMID: 25124594)

Informacja